Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism
Accumulating evidences suggested an association between gut microbiome dysbiosis and impaired glycemic control. Ginsenoside Rb1 (Rb1) is a biologically active substance of ginseng, which serves anti-diabetic effects. However, its working mechanism especially interaction with gut microbes remains elu...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a8edb6264dd41349f8eb9444e748381 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6a8edb6264dd41349f8eb9444e748381 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6a8edb6264dd41349f8eb9444e7483812021-11-30T18:59:52ZGinsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism1663-981210.3389/fphar.2021.756491https://doaj.org/article/6a8edb6264dd41349f8eb9444e7483812021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.756491/fullhttps://doaj.org/toc/1663-9812Accumulating evidences suggested an association between gut microbiome dysbiosis and impaired glycemic control. Ginsenoside Rb1 (Rb1) is a biologically active substance of ginseng, which serves anti-diabetic effects. However, its working mechanism especially interaction with gut microbes remains elusive in detail. In this study, we investigated the impact of Rb1 oral supplementation on high fat diet (HFD) induced obesity mice, and explored its mechanism in regulating blood glucose. The results showed that higher liver weight and lower cecum weight were observed in HFD fed mice, which was maintained by Rb1 administration. In addition, Rb1 ameliorated HFD induced blood lipid abnormality and improved insulin sensitivity. Several mRNA expressions in the liver were measured by quantitative real-time PCR, of which UCP2, Nr1H4, and Fiaf were reversed by Rb1 treatment. 16S rRNA sequencing analysis indicated that Rb1 significantly altered gut microbiota composition and increased the abundance of mucin-degrading bacterium Akkermansia spp. compared to HFD mice. As suggested via functional prediction, amino acid metabolism was modulated by Rb1 supplementation. Subsequent serum amino acids investigation indicated that several diabetes associated amino acids, like branched-chain amino acids, tryptophan and alanine, were altered in company with Rb1 supplementation. Moreover, correlation analysis firstly implied that the circulation level of alanine was related to Akkermansia spp.. In summary, Rb1 supplementation improved HFD induced insulin resistance in mice, and was associated with profound changes in microbial composition and amino acid metabolism.Xueyuan YangBangjian DongBangjian DongLijun AnQi ZhangYao ChenHonglin WangZiteng SongFrontiers Media S.A.articleginsenoside Rb1insulin sensitivitygut microbiotaamino acid metabolismcorrelation analysisTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
ginsenoside Rb1 insulin sensitivity gut microbiota amino acid metabolism correlation analysis Therapeutics. Pharmacology RM1-950 |
spellingShingle |
ginsenoside Rb1 insulin sensitivity gut microbiota amino acid metabolism correlation analysis Therapeutics. Pharmacology RM1-950 Xueyuan Yang Bangjian Dong Bangjian Dong Lijun An Qi Zhang Yao Chen Honglin Wang Ziteng Song Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism |
description |
Accumulating evidences suggested an association between gut microbiome dysbiosis and impaired glycemic control. Ginsenoside Rb1 (Rb1) is a biologically active substance of ginseng, which serves anti-diabetic effects. However, its working mechanism especially interaction with gut microbes remains elusive in detail. In this study, we investigated the impact of Rb1 oral supplementation on high fat diet (HFD) induced obesity mice, and explored its mechanism in regulating blood glucose. The results showed that higher liver weight and lower cecum weight were observed in HFD fed mice, which was maintained by Rb1 administration. In addition, Rb1 ameliorated HFD induced blood lipid abnormality and improved insulin sensitivity. Several mRNA expressions in the liver were measured by quantitative real-time PCR, of which UCP2, Nr1H4, and Fiaf were reversed by Rb1 treatment. 16S rRNA sequencing analysis indicated that Rb1 significantly altered gut microbiota composition and increased the abundance of mucin-degrading bacterium Akkermansia spp. compared to HFD mice. As suggested via functional prediction, amino acid metabolism was modulated by Rb1 supplementation. Subsequent serum amino acids investigation indicated that several diabetes associated amino acids, like branched-chain amino acids, tryptophan and alanine, were altered in company with Rb1 supplementation. Moreover, correlation analysis firstly implied that the circulation level of alanine was related to Akkermansia spp.. In summary, Rb1 supplementation improved HFD induced insulin resistance in mice, and was associated with profound changes in microbial composition and amino acid metabolism. |
format |
article |
author |
Xueyuan Yang Bangjian Dong Bangjian Dong Lijun An Qi Zhang Yao Chen Honglin Wang Ziteng Song |
author_facet |
Xueyuan Yang Bangjian Dong Bangjian Dong Lijun An Qi Zhang Yao Chen Honglin Wang Ziteng Song |
author_sort |
Xueyuan Yang |
title |
Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism |
title_short |
Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism |
title_full |
Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism |
title_fullStr |
Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism |
title_full_unstemmed |
Ginsenoside Rb1 ameliorates Glycemic Disorder in Mice With High Fat Diet-Induced Obesity via Regulating Gut Microbiota and Amino Acid Metabolism |
title_sort |
ginsenoside rb1 ameliorates glycemic disorder in mice with high fat diet-induced obesity via regulating gut microbiota and amino acid metabolism |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/6a8edb6264dd41349f8eb9444e748381 |
work_keys_str_mv |
AT xueyuanyang ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism AT bangjiandong ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism AT bangjiandong ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism AT lijunan ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism AT qizhang ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism AT yaochen ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism AT honglinwang ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism AT zitengsong ginsenosiderb1amelioratesglycemicdisorderinmicewithhighfatdietinducedobesityviaregulatinggutmicrobiotaandaminoacidmetabolism |
_version_ |
1718406329945554944 |